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Abstract 
AIM: Acceleration of orthodontic tooth movement has gained a massive interest to decrease the total treatment 
time. Local pharmacological agents might be used for that purpose as a practical, effective and inexpensive 
alternative. A systematic review was achieved to evaluate the evidence in that topic. 
METHODS: A search was conducted on electronic databases including PubMed, Lilacs, Web of Science 
(Thompson Reuters), EMBASE (OvidSP), and Cochrane Database of Systematic Reviews (Wiley) in addition to 
hand searching of relevant journals till June 2018. Only studies written in English were utilised. Publications were 
selected, assessed systematically and graded by two observers according to Bondemark grading system. 
RESULTS: Only two human studies were found investigating the effect of Relaxin and Prostaglandins in the rate 
of orthodontic tooth movement. No obvious side effects were reported. Relaxin showed no increase in the rate of 
tooth movement while prostaglandin showed a marked increase in the rate of orthodontic tooth movement. 
CONCLUSION: There is below moderate evidence showing no effect of relaxin on orthodontic tooth movement, 
while inconclusive evidence was found regarding Prostaglandin in the acceleration of orthodontic tooth 
movement. More prospective well-conducted clinical trials are needed to reach a proper conclusion regarding the 
local pharmacological agents which can be safely used to accelerate orthodontic tooth movement. 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Orthodontic tooth movement has been 
defined as the production of a biological reaction to an 
interruption in the physiological equilibrium related to 
the dentofacial complex by an externally applied force 
[1]. 
The lengthy duration of orthodontic treatment 
is considered a major disadvantage. This may lead to 
loss of patient compliance. This may be considered a 
problem especially for patients who require extraction 
of teeth as the treatment takes a relatively longer 
period than patients who don’t require extraction of 
teeth [2]. This may also lead to increasing the risk of 
caries [3]
 
and periodontal breakdown [4]. Therefore, 
attention was paid to find methods to accelerate 
orthodontic tooth movement [5]. These methods were 
surgical, mechanical or physical. Examples of these 
methods are low-level laser therapy, corticotomy, 
electrical current, pulsed electromagnetic fields, and 
dentoalveolar or periodontal distraction. Evidence 
showed that corticotomy is effective and safe to 
accelerate orthodontic tooth movement [5]. Unluckily, 
very few patients can accept this surgical intervention 
to accelerate tooth movement due to its aggressive 
and invasive nature. 
Another direction was focused on 
pharmacological approaches either locally or systemic 
administration to accelerate orthodontic tooth 
movement [6], [7].  
Most of the previous systematic reviews 
concentrated on the physiological and surgical 
interventions with little concentration on the 
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pharmacological interventions [5], [8], [9], [10]. 
This systematic review aims to investigate - in 
a systemic methodology and critical analysis - the 
available scientific literature discussing locally 
administrated pharmacological agents used in the 
acceleration of orthodontic tooth movement in 
humans. 
 
 
Material and Methods 
 
This section was written following the 
PRISMA 2009 checklist [11].  
 
Protocol and Registration 
There was neither a detailed protocol nor a 
systematic review registration done. 
 
Information Sources and Search strategy 
A search was conducted on electronic 
databases including PubMed, Lilacs, Web of Science 
(Thompson Reuters), EMBASE (OvidSP), and 
Cochrane Database of Systematic Reviews (Wiley) in 
addition to hand searching of relevant journals till 
June 2018. Only studies written in English were 
utilised. 
The terms used in the search were shown in 
Table 1. 
Table 1: Terms used in the search strategy of the systematic 
review 
PICO item Synonyms 
P Orthodontic patient OR Orthodontic therapy OR Orthodontic 
treatment Or Orthodox* Or Tooth Movement (Mesh) OR teeth 
I Pharmacological OR Drug Or Local Factor OR Pharmacol* OR 
vitamin D OR Prostaglandin OR Cholecalciferol 
C Control OR Regular Orthodontic treatment 
O Accelerate tooth movement OR Fast treatment OR Treatment 
time OR Accelerate* movement OR Rapid tooth movement OR 
Quick treatment 
 
Eligibility Criteria 
The PICOS format (P = Population, I = 
Intervention, C = Comparison, O = Outcome, S = 
Study design) was constructed in order to state a 
clinical question with particular inclusion criteria. 
P - Patients at any age undergoing 
orthodontic tooth movement 
I - Local pharmacological interventions to 
accelerate tooth movement 
C - Conventional orthodontic therapy without 
local pharmacological intervention.  
O - Rate of tooth movement  
S - Randomized controlled studies and non-
randomized controlled studies 
Inclusion criteria: - Local intervention; - 
Injectable; - Clinical trials; - Trial aiming to accelerate 
tooth movement. 
Exclusion Criteria: - Animal study; - Systemic 
drug; - Histological study; - Trial comparing drugs 
decelerating tooth movement; - Subcutaneous, 
Intramuscular, Intravenous administration. 
 
Review question  
Are the local pharmacological interventions 
able to accelerate tooth movement compared to 
conventional orthodontic treatment without local 
pharmacological intervention? 
 
Study selection 
Two independent reviewers examined the 
article titles and abstracts. Full-text articles were 
retrieved when the articles were either potentially 
eligible or when the eligibility criteria couldn’t be 
determined. Full-text articles were assessed following 
the inclusion and exclusion criteria. Reviewers’ results 
were compared. Discussion of the data was done to 
resolve any disagreement.  
 
Data Items 
From the studies that met our inclusion 
criteria, specific data items were extracted including 
(drug, frequency, dose, site, duration, total, 
dose, control, appliance, outcome, Risk Ratio, Mean 
Deference and side effects). 
 
Data collection 
The data items were extracted independently 
by 2 reviewers. The results were compared for 
accuracy and reassessment of the extracted data was 
done in case of any discrepancy until resolving the 
disagreement.  
 
Bias Assessment  
A quality assessment was performed based 
on the method described by Bondemark et al. [12, 
[13]. Following this method, studies were assigned to 
the grading of A, B, & C. A was considered high-
quality evidence, B was a moderate value of evidence 
and C was considered the low value of evidence. In 
case of disagreement between the two reviewers or 
inadequately described criteria, the study was 
discussed thoroughly until reaching a consensus 
(Table 2). 
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Table 2 : Bondemark grading system 
Grade A Grade B Grade C 
All criteria should be met: 
A randomised clinical study 
or a prospective study 
Diagnostic reliability tests 
and reproducibility tests  
described 
Defined diagnosis and 
endpoints 
Blinded outcome assessment 
All criteria should be met: 
Cohort study or retrospective 
case series with defined 
control or reference group 
Diagnostic reliability tests 
and reproducibility tests 
described 
Defined diagnosis and 
endpoints 
One or more of the 
conditions below: 
The high rate of attrition (1/3 
or more of subjects lost 
during the study) 
Poorly defined patient 
material 
Unclear diagnosis and 
endpoints 
 
   
Summary measures and synthesis of the 
results 
The final level of evidence was determined 
based on Bondemark et al., [12] The protocol divided 
evidence level to 1 (strong), 2 (moderate), 3 (limited) 
and 4 (inconclusive) (Table3). 
Table 3: Evidence level 
Level Evidence Definition 
1 Strong Minimum of 2 studies level A 
2 Moderate At least 1 study level A and two studies level B 
3 Limited Minimum of 2 studies level B 
4 Inconclusive Less than 2 studies level B 
 
 
Approach to Data synthesis  
A meta-analysis was considered if the 
available collected data was adequate. 
 
 
Results 
 
Study selection  
A flowchart showed the selection process in 
each stage of the systematic review. (Figure 1) Five 
hundred seventy-eight articles were excluded by title 
and abstract while 4 articles were selected for full 
review. Two of these articles weren’t written in English 
[14], [15].  
Two articles were included in our review 
utilising relaxin [16] and prostaglandin [17] as local 
pharmacological interventions aiming to accelerate 
tooth movement.  
 
Study characteristics 
Methods. One study was a randomised 
controlled study while the other study was a 
prospective study which was divided into 3 phases. 
Subjects. Total of 65 patients was involved in both 
studies. Intervention. Relaxin hormone and 
prostaglandin were used in selected studies. 
 
Quality assessment  
One study was graded A (High value of 
evidence) [16], while the other was graded B 
(moderate level of evidence) [17]. 
 
Results of Individual Studies  
The primary outcome assessed in both 
studies was the effect of the local agent in the 
acceleration of orthodontic tooth movement. 
Secondary outcome included side effects resulted 
from using prostaglandin and effect of Relaxin on 
relapse (Table 4). The effect of prostaglandin was 
investigated both macroscopically and using 
radiographic images. There was no side effect 
observed on the gingiva or bones. Relaxin showed no 
effect on short-term stability.  
Table 4: Results of individual data 
Title Author Year Design of the 
study 
Number Groups Split-mouth 
A randomized, placebo-
controlled clinical trial 
on the effects of 
recombinant human relaxin 
on tooth movement and 
short-term stability 
Susan P. 
McGorray, a 
Calogero Dolce,b 
Susan Kramer,c 
Dennis Stewart,d 
and Timothy T. 
Wheelere 
2012 RCT 40 2 no 
Clinical application of 
prostaglandin E1 (PGE1) 
upon orthodontic tooth 
movement. 
Yamasaki, K 
Shibata, Y.Imai, 
STani, 
Y.Shibasaki, Y 
Fukuhara, T 
1984 3 phases 25 3 yes 
 
Title Drug  Sam
ple 
Frequen
cy 
Dose Site Dur
atio
n 
Tot
al 
do
se 
Contro
l 
Applianc
e and 
force 
A randomized, 
placebo-
controlled 
clinical trial 
on the effects 
of recombinant 
human relaxin 
on tooth 
movement and 
short-term 
stability 
Human 
relaxin 
 40 /7 days 25µg/site/0.
1 ml 
2 sites buccal 
and lingual of 
the target teeth 
56 40
0µ
g 
Vehicl
e 1.6 
ml 
 
 
Invisalig
n 
vacuum 
aligners 
Clinical 
application of 
prostaglandin 
E1 (PGE1) 
upon 
orthodontic 
tooth 
movement. 
PGE1 Phase 
I 
9 3 to 5 
times 
10 µg PGE1 Injection of the 
submucosal 
area of the 
buccal side of 
the first 
premolar 
Up 
to 
26 
day
s 
 Lidoca
ine 
Double 
spring 
soldered 
on 
lingual 
arch(100 
gm) 
Phase 
II 
8 3 to 4 
times 
10 µg PGE1 Injection of the 
submucosal 
area distal to 
the canine 
Up 
to 
21 
day
s 
 Lidoca
ine 
Sectiona
l 
contracti
on loop 
(150 gm) 
Phase 
III 
8 5 to 13 
times 
10 µg PGE1 Injection of the 
submucosal 
area distal to 
the canine 
Up 
to 5 
mo
nth
s 
 Lidoca
ine 
Compres
sed 
open- 
coil 
springs 
or 
ringlets 
(150 
grams) 
 
  Title Outcome 
Frequency 
days 
Duration 
(days) 
Dose 
Mean 
difference 
(intervention/c
ontrol) 
(ratio) 
Side effects 
A randomized, 
placebo-controlled 
clinical trial 
on the effects of 
recombinant human 
relaxin 
on tooth movement 
and short-term 
stability 
 
Rate of tooth 
movement, 
rate of relapse 
/7 56 
25µg/site/0.
1 ml 
1 No 
Clinical application of 
prostaglandin e1 
(pge1) upon 
orthodontic tooth 
movement. 
Otm and side 
effect was 
examined 
macroscopicall
y 
3 to 5 times 
in 26 days 
15-28 
10 µg pge1 
2.14±0.33 
No 
3 to 4 times 
in 14 days 
10-21 
Not 
mentioned 
5 to 13 
times 
45-144 1.6 ±0.09 
 
Risk of bias  
The study investigating Prostaglandin effect 
was found to be of high risk of bias as it was not a 
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randomised controlled trial, while some concerns 
regarding the allocation concealment were detected in 
the other study investigating Relaxin effect. 
 
Figure 1: Prisma flow chart 
 
 
Synthesis of Data  
A meta-analysis was not possible due to the 
presence of insufficient studies. 
 
 
Discussion  
 
This study aimed to investigate the ability of 
the local pharmacological agent to accelerate 
orthodontic tooth movement. Surgical interventions 
have shown potential in the acceleration of 
orthodontic movement [8]. Its side effects had always 
been a barrier in the generalisation of these 
interventions. Local pharmacological interventions 
would be an excellent replacement if proven their 
efficiency, especially if not accompanied by any side 
effects. In spite of the huge focus on the acceleration 
of orthodontic tooth movement, there were only 2 
human studies investigating the effect of local 
pharmacological agents on the acceleration of OTM. 
There were much more animal studies [18], [19], [20], 
[21] on the same topic. The obvious reason was the 
risk of side effects that accompany the tested 
interventions [22].  
From the current systematic review, Relaxin 
[16] and Prostaglandin [17] were tested on humans. 
Prostaglandin showed a marked increase in OTM. 
The study was divided into 3 phases in which all 
phases showed acceleration of OTM in intervention 
sides, yet the study was considered having a high risk 
of bias. The study wasn’t a randomised controlled 
study, and the sample size wasn’t enough for each 
phase. 
Evidence level was below moderate regarding 
Relaxin and inconclusive regarding prostaglandin 
according to Bondemark grading system [12]. Only 1 
study was found which was graded A for Relaxin. 
While for Prostaglandin, only one study which was 
graded B was found.  
The RCT investigating Relaxin showed that 
there was no significant difference and was 
considered of low risk of bias. Yet they used aligners 
which might not have delivered a consistent force-that 
couldn’t be measured-necessary for proper 
comparison. Both studies were based on submucosal 
injection in the areas adjacent to OTM.  
This study showed the need for further 
studies investigating the use of local pharmacological 
agents in the acceleration of orthodontic tooth 
movement. 
 
Strength and limitations 
Previous studies investigated different 
approaches with no concentration on the 
pharmacological approaches [23]. This study, 
however, focused on the local pharmacological agents 
used in orthodontic treatment to accelerate tooth 
movement. There were not enough studies to conduct 
a meta-analysis. There were only a few heterogynous 
human studies. The quality of evidence was poor in 
that topic indicating the need for further studies to 
reach a proper conclusion.  
 
 
Conclusion 
 
There is below moderate evidence showing 
no effect of relaxin on orthodontic tooth movement, 
while inconclusive evidence was found regarding 
Prostaglandin in the acceleration of orthodontic tooth 
movement. More prospective well-conducted clinical 
trials are needed to reach a proper conclusion 
regarding the local pharmacological agents which can 
be safely used to accelerate orthodontic tooth 
movement. 
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